Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
290.05
+43.00 (17.41%)
Aug 1, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Life Science
1.03B
Log In
Log In
Log In
Log In
Upgrade
Life Science Growth
-7.43%
Log In
Log In
Log In
Log In
Upgrade
Clinical Diagnostics
1.54B
Log In
Log In
Log In
Log In
Upgrade
Clinical Diagnostics Growth
1.34%
Log In
Log In
Log In
Log In
Upgrade
Other Segments
500.00K
Log In
Log In
Log In
Log In
Upgrade
Other Segments Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Life Science Operating Profit
-
Log In
Log In
Log In
Log In
Upgrade
Life Science Operating Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
Clinical Diagnostics Operating Profit
-
Log In
Log In
Log In
Log In
Upgrade
Clinical Diagnostics Operating Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other Segments Operating Profit
-
Log In
Log In
Log In
Log In
Upgrade
Other Segments Operating Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Gross Income by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
820.00%
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
820.00%
Log In
Log In
Log In
Log In
Upgrade
Life Science Segment Profit
582.40M
Log In
Log In
Log In
Log In
Upgrade
Life Science Segment Profit Growth
-2.51%
Log In
Log In
Log In
Log In
Upgrade
Clinical Diagnostics Segment Profit
796.60M
Log In
Log In
Log In
Log In
Upgrade
Clinical Diagnostics Segment Profit Growth
-8.59%
Log In
Log In
Log In
Log In
Upgrade
Other Segments Segment Profit
-100.00K
Log In
Log In
Log In
Log In
Upgrade
Other Segments Segment Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
820.00%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
United States
1.04B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-4.41%
Log In
Log In
Log In
Log In
Upgrade
EMEA
834.10M
Log In
Log In
Log In
Log In
Upgrade
EMEA Growth
2.27%
Log In
Log In
Log In
Log In
Upgrade
APAC
521.60M
Log In
Log In
Log In
Log In
Upgrade
APAC Growth
-6.59%
Log In
Log In
Log In
Log In
Upgrade
Other Regional
169.30M
Log In
Log In
Log In
Log In
Upgrade
Other Regional Growth
0.48%
Log In
Log In
Log In
Log In
Upgrade